Yayınlar & Eserler

Yayın Ağı
Makaleler 3
Tümü (3)
SCI-E, SSCI, AHCI (3)
SCI-E, SSCI, AHCI, ESCI (3)
Scopus (3)

1. Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment

Sahin G., AKBAL DAĞISTAN Ö., Culha M., Erturk A., Basarir N. S., SANCAR S., et al.
JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.111, sa.10, ss.2652-2661, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

2. Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis

YILDIZ PEKÖZ A., AKBAL DAĞISTAN Ö., Fael H., Culha M., Erturk A., Basarir N. S., et al.
Drug Delivery , cilt.29, sa.1, ss.2846-2854, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

3. Early effects of low molecular weight heparin therapy with soft-mist inhaler for covid-19-induced hypoxemia: A phase iib trial

Erelel M., KAŞKAL M., AKBAL DAĞISTAN Ö., Issever H., Dagistanli A. S., Balkanci H., et al.
Pharmaceutics , cilt.13, sa.11, 2021 (SCI-Expanded, Scopus) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 7

1. Local Lung Targeting During COVID-19 / Favipiravir Preclinic Study

YILDIZ PEKÖZ A., AKBAL DAĞISTAN Ö., HANAN F., ŞAHİN G., ÇULHA M., ERTÜRK A., et al.
7th Workshop on Pulmonary Drug Delivery (PDD 2022), Dublin, İrlanda, 20 - 22 Nisan 2022, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Local Lung Targeting During COVID-19 / Inhalation Formulaton of Favipiravir

AKBAL DAĞISTAN Ö., HANAN F., ŞAHİN G., ÇULHA M., ERTÜRK A., BAŞARIR N. S., et al.
7th Workshop on Pulmonary Drug Delivery (PDD 2022), Dublin, İrlanda, 20 - 22 Nisan 2022, (Özet Bildiri)

3. A New Oro-Dispersible Tablet Formulation of An Antihypertensive Drug

GÜLTEKİN Y., ÖZTÜRK N., ŞAHİN G., PEZİK E., KARA A., VURAL İ.
13th International Symposium on Pharmaceutical Sciences (ISOPS 2021), Çevrim-içi, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri)

4. Chitosan Nanoparticles for Lung Cancer Treatment: Preformulation Study

ŞAHİN G., SALEEM I., YILDIZ PEKÖZ A.
6th Pulmonary Drug Delivery Workshop (PDD 2019), 11 - 13 Eylül 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Formulation of Microfluidics-Based Chitosan Nanoparticles and Characterization of Particle Size

ŞAHİN G., SALEEM I., YILDIZ PEKÖZ A.
19th International Pharmaceutical Technology Symposium (IPTS 2018), 17 - 19 Eylül 2018, (Tam Metin Bildiri)

6. Dissolution Profiles Of Fosinopril Sodıum Orodispersible Tablets and Orodispersible Films

ŞAHİN G., ÖZTÜRK N., VURAL İ.
18th International Pharmaceutical Technology Symposium (IPTS 2016), 18 - 21 Eylül 2016, (Tam Metin Bildiri)

7. Development and Evaluation of Orally Disintegrating Tablets of Fosinopril Sodium by Direct Compression Method

ŞAHİN G., ÖZTÜRK N., VURAL İ.
1st Gazi Pharma Symposium Series (GPSS-2015), 12 - 15 Kasım 2015, (Özet Bildiri)
Metrikler

Yayın

10

Yayın (WoS)

3

Yayın (Scopus)

3

Atıf (WoS)

49

H-İndeks (WoS)

3

Atıf (Scopus)

56

H-İndeks (Scopus)

3

Proje

1
BM Sürdürülebilir Kalkınma Amaçları